Overactive bladder Trials in Los Angeles, United States
Conditions / Overactive bladder / Los Angeles, United States
Overactive bladder is a medical condition with active clinical research programs worldwide.
19 total trials for this combination
Showing top 10 of 19 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03902080 | Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) | COMPLETED | PHASE3 |
| NCT01868516 | Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overactive Bladder | COMPLETED | PHASE2 |
| NCT02045862 | A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive Bladder | COMPLETED | PHASE3 |
| NCT02660138 | Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1 | TERMINATED | PHASE3 |
| NCT01972841 | This Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder | COMPLETED | PHASE3 |
| NCT03492281 | A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) | COMPLETED | PHASE3 |
| NCT02757768 | A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) | COMPLETED | PHASE4 |
| NCT00685113 | A Clinical Trial to Evaluate the Efficacy and Safety of DR-3001 in Women With Overactive Bladder | COMPLETED | PHASE3 |
| NCT03475706 | Evaluation of the Efficacy and Safety of Solabegron Tablets for Treatment of Overactive Bladder in Adult Women | COMPLETED | PHASE2 |
| NCT03583372 | An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB). | COMPLETED | PHASE3 |